To find out more about a company click on the company name to see a brief profile.
Archived News Headlines
We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.
Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
House Health Care Reform Legislation Would Dramatically Improve the Health Care System for People With Cancer
(American Cancer Society) Nov 5, 2009 – The American Cancer Society Cancer Action Network (ACS CAN) today announced its support of proposed health care legislation that will be debated this week in the U.S. House of Representatives. In a letter to House leaders, ACS CAN, the advocacy affiliate of the American Cancer Society, said the proposed legislation has the potential to take the fight against cancer in this country to a new level.
read press release 
ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
(Yahoo! Finance) Nov 6, 2009 - ZIOPHARM Oncology, Inc. presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma.
read article
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting
(CNBC.com) Nov 6, 2009 - Oncolytics Biotech Inc. today announced updated results from a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung in a poster presentation at the 15th Annual Connective Tissue Oncology Society Meeting held in Miami Beach, Florida, from November 5th to 7th.
read article
Threshold Pharmaceuticals Presents Interim Data From a Phase 1/2 Clinical Trial of TH-302 at Sarcoma Meeting
(CNNMoney.com) Nov 6, 2009 - Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302.
read article
Report: Over 100,000 Cancers Linked to Excess Body Fat
(American Cancer Society) Nov 6, 2009 - More than 100,000 cancers in the US each year are linked to excess body fat, according to data released Thursday by the American Institute for Cancer Research (AICR).
read press release
Early Morning Colonoscopies May Find More Polyps
(BusinessWeek.com) Nov 6, 2009 - Early morning colonoscopies detect more polyps than colon cancer screenings done later in the day, and the number of polyps found decreases by the hour as the day progresses, a new study has found.
read article
New Optical Tool Could Produce ‘Virtual Biopsies’ in Brain Cancer Cases
(Johns Hopkins) Nov 4, 2009 - As a Johns Hopkins electrical engineer, Jin U. Kang has spent years tinkering with lasers and optical fiber, studying what happens when light strikes matter. Now, he’s taking on a new challenge: brain surgery.
read press release
Researcher: ‘Optical Biopsy’ for Breast Cancer Increasingly Accurate
(University of Florida) Nov 5, 2009 - Most biopsies following mammograms reveal benign abnormalities, not cancer. But women may not have to endure the medical costs, stress and potential complications that accompany such invasive biopsies forever.
read press release
Biotech Stock Mailbag: Poniard Predictions
(TheStreet.com) Nov 6, 2009 - Let's open the Biotech Stock Mailbag, beginning with an email from Leslie O. about a very important event looming for Poniard Pharmaceuticals. Writes Leslie, "Adam, what's your prediction for results from Poniard's phase III study of picoplatin in small cell lung cancer?"
read article
Lymphoma Research Foundation Announces New Chief Executive Officer
(LRF) Nov 6, 2009 – The Lymphoma Research Foundation (LRF), the nation's largest lymphoma-focused voluntary health organization devoted exclusively to funding lymphoma research and providing patients and health care professionals with critical information on the disease, today announced that it has chosen Diane Blum to become its next Chief Executive Officer, effective January 25, 2010.
read press release
Obama Welcomes AARP Backing of Health Care Bill
(BusinessWeek.com) Nov 5, 2009 - President Barack Obama trumpeted two major endorsements for his health overhaul push Thursday as House Democratic leaders pushed toward a vote Saturday on the far-reaching legislation remaking the U.S. health care system.
read article
Generics Makers Line Up To Sell Copies Of Pfizer's Lipitor
(CNNMoney.com) Nov 6, 2009 - More generic-drug makers have filed for U.S. approval to market generic versions of Pfizer Inc.'s blockbuster cholesterol pill Lipitor.
read article
Roche, HSBC, Novartis Probed by Korea FDA on Tamiflu
(Bloomberg) Nov 6, 2009 - Roche Holdings AG, maker of the Tamiflu antiviral treatment, is under investigation in South Korea over sales of the drug to private companies as the number of swine flu cases jumped.
read article
Amgen's Vectibix Misses Survival Goal, But Sales Could Benefit
(CNNMoney.com) Nov 5, 2009 - Amgen Inc.'s cancer drug Vectibix failed to improve overall survival in a study as initial treatment for advanced colorectal cancer patients, but some believe the data could help boost sales.
read article
Shorter, More Intense Radiation OK for Some Breast Cancers
(BusinessWeek.com) Nov 4, 2009 - A shorter, more intense course of whole-breast radiation works as well as the traditional six-week course, at least for some early-stage breast cancers, a new study shows.
read article
PSA Reading Could Predict Post-Radiation Survival
(U.S. News & Worl Report) Nov 4, 2009 - Prostate cancer patients whose prostate-specific antigen (PSA) levels rise within 18 months after radiotherapy have an increased risk of death, say U.S. researchers.
read article
Focused Radiation May Help Some With Lung Cancer
(U.S. News & World Report) Nov 4, 2009 - Three-year survival was 100 percent for people with early-stage lung cancer and good lung function who were treated with radical stereotactic radiosurgery using CyberKnife, according to a new study funded by the product's maker.
read article
Approved Lymphoma Drug Shows Promise in Early Tests Against Bone Cancer
(CNBC.com) Nov 5, 2009 - A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today in the International Journal of Cancer.
read article
Experimental Agent Reduces Breast Cancer Metastasis to Bone
(Tufts University School of Medicine) Nov 3, 2009 - Researchers have reduced breast cancer metastasis to bone using an experimental agent to inhibit ROCK, a protein that was found to be over-expressed in metastatic breast cancer.
read press release
Experimental Vaccine Cures Pre-Cancer Vulvar Growths
(Reuters) Nov 5, 2009 - An experimental vaccine cured nearly half of women with pre-cancerous growths on their genitals, producing major improvement in nearly four out of five, researchers in the Netherlands reported on Wednesday.
read article
ERYtech Pharma Starts its Pivotal Clinical Trial for GRASPA(R) in Acute Lymphoblastic Leukaemia
(CNBC.com) Nov 5, 2009 - ERYtech Pharma announces the start of its pivotal clinical trial for GRASPA(R), its lead product in Acute Lymphoblastic Leukaemia. This phase III trial has begun in France and will be enlarged to a European scale.
read article
Does Green Tea Prevent Cancer? Evidence Continues to Brew, But Questions Remain
(AACR) Nov 5, 2009 - Although scientists are reluctant to officially endorse green tea as a cancer prevention method, evidence continues to grow about its protective effects, including results of a new study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, which suggests some reduction in oral cancer.
read press release
U.S. Health Care Gets Cancer Right
(Forbes.com) Nov 5, 2009 - As the Senate and House present their health care reform bills, Al Franken, Minnesota's junior senator, disputes the well-established fact that America has higher cancer survival rates than Europe--even though his state's Mayo Clinic, perhaps the most sophisticated medical center in the world, has developed path-breaking treatments for cancer.
read article
Sunesis' Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia
(Yahoo! Finance) Nov 5, 2009 - Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML).
read article
ABRAXANE® Receives Orphan Drug Status for the Treatment of Pancreatic Cancer and Stage IIB-IV Melanoma
(Reuters) Nov 5, 2009 - Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted orphan drug designation to the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the treatment of pancreatic cancer as well as stage IIB-IV melanoma.
read article
